36. Zahra Vahdat Shariatpanahi et al., “Effects of Early Enteral Glutamine Supplementation on Intestinal Permeability in Critically Ill Patients,” Indian Journal of Critical Care Medicine 23, no. 8 (август 2019): 356–362, doi: 10.5005/jp-journals1007123218.
37. Xi Peng et al., “Effects of Enteral Supplementation with Glutamine Granules on Intestinal Mucosal Barrier Function in Severe Burned Patients,” Burns 30, no. 2 (март 2004): 135–139, doi: 10.1016/j.burns.2003.09.032.
38. Raymond John Playford and Michael James Weiser, “Bovine Colostrum: Its Constituents and Uses,” Nutrients 13, no. 1 (январь 2021): 265, doi: 10.3390/nu13010265.
39. Maciej Halasa et al., “Oral Supplementation with Bovine Colostrum Decreases Intestinal Permeability and Stool Concentrations of Zonulin in Athletes,” Nutrients 9, no. 4 (апрель 2017): 370, doi: 10.3390/nu9040370.
40. Grégoire Wieërs et al., “How Probiotics Affect the Microbiota,” Frontiers in Cellular and Infec tion Microbiology 9 (15 января 2020): 454, doi: 10.3389/fcimb.2019.00454.
41. Jing Cheng, Arja Laitila, and Arthur C. Ouwehand, “Bifidobacterium animalis subsp. lactis HN019 Effects on Gut Health: A Review,” Frontiers in Nutrition 8 (14 декабря 2021): 790561, doi: 10.3389/fnut.2021.790561.
42. Jason C. Sniffen et al., “Choosing an Appropriate Probiotic Product for Your Patient: An Evidencebased Practical Guide,” PLoS One 13, no. 12 (26 декабря 2018): doi: 10.1371/journal.pone.0209205.
43. Antonella Orlando et al., “Lactobacillus rhamnosus GG Protects the Epithelial Barrier of Wistar Rats from the PepsinTrypsinDigested Gliadin (PTG)Induced Enteropathy,” Nutrients 10, no. 11 (7 ноября 2018): 1698, doi: 10.3390/nu10111698.
44. Kulandaipalayam N.C. Sindhu et al., “Immune Response and Intestinal Permeability in Children with Acute Gastroenteritis Treated with Lactobacillus Rhamnosus GG: A Randomized, Doubleblind, Placebocontrolled Trial,” Clinical Infectious Diseases 58, no. 8 (апрель 2014): 1107–1115, doi: 10.1093/cid/ciu065.
45. Lucio Capurso, “Thirty Years of Lactobacillus rhamnosus GG: A Review,” Journal of Clinical Gastroenterology 53, suppl. 1 (март 2019): S1–S41, doi: 10.1097/MCG.0000000000001170.
46. Vibeke Rosenfeldt et al., “Effect of Probiotics on Gastrointestinal Symptoms and Small Intestinal Permeability in Children with Atopic Dermatitis,” The Journal of Pediatrics 145, no. 5 (ноябрь 2004): 612–616, doi: 10.1016/j.jpeds.2004.06.068.
47. Beneficial Probiotics, http://www.floraactive.com/.
48. Cheng, “Bifidobacterium animalis,” 790561.
49. David Groeger et al., “Bifidobacterium infantis 35624 Modulates Host Inflammatory Processes Beyond the Gut,” Gut Microbes 4, no. 4 (1 июля 2013): 325–339, doi: 10.4161/gmic.25487.
50. Peter J. Whorwell et al., “Efficacy of an Encapsulated Probiotic Bifidobacterium infantis 35624 in Women with Irritable Bowel Syndrome,” The American Journal of Gastroenterology 101, no. 7 (июль 2006): 1581–1590, doi: 10.1111/j.15720241.2006.00734.x.
51. Marcin Lukaszewicz, “Saccharomyces cerevisiae var. boulardii– Probiotic Yeast,” Probiot ics, Everlon Rigobelo, ed. (London: IntechOpen Limited, 3 октября 2012): 385–398, doi: 10.5772/50105.
52. Ener Cagri Dinleyici et al., “Saccharomyces boulardii CNCM I-745 in Different Clinical Conditions,” Expert Opinion on Biological Therapy 14, no. 11 (ноябрь 2014): 1592–1609, doi: 10.1517/14712598.2014.937419.
53. Eduardo Garcia Vilela et al., “Influence of Saccharomyces boulardii on the Intestinal Permeability of Patients with Crohn’s Disease in Remission,” Scandinavian Journal of Gastroenterology 43, no. 7 (2008): 842–848, doi: 10.1080/00365520801943354.
54. Pedro Pais et al., “Saccharomyces boulardii: What Makes it Tick as Successful Probiotic?”, Jour nal of Fungi 6, no. 2 (июнь 2020): 78, doi: 10.3390/jof6020078.
55. Shahin Ayazi et al., “Measurement of Gastric pH in Ambulatory Esophageal pH Monitoring,” Surgical Endoscopy 23, no. 9 (сентябрь 2009): 1968–1973, doi: 10.1007/s004640080218-0.
56. Hrair P. Simonian et al., “Regional Postprandial Differences in pH within the Stomach and Gastroesophageal Junction,” Digestive Diseases and Sciences 50, no. 12 (декабрь 2005): 2276–2285, doi: 10.1007/s106200053048-0.
57. T.A. Tompkins, I. Mainville, and Y. Arcand, “The Impact of Meals on a Probiotic During Transit through a Model of the Human Upper Gastrointestinal Tract,” Beneficial Microbes 2, no. 4 (декабрь 2011): 295–303, doi: 10.3920/BM2011.0022.
58. M. Kilian et al., “The Oral Microbiome— An Update for Oral Healthcare Professionals,” British Dental Journal 221 (18 ноября 2016): 657–666, doi: 10.1038/sj.bdj.2016.865.
59. Priya Nimish Deo and Revati Deshmukh, “Oral Microbiome: Unveiling the Fundamentals,” Journal of Oral and Maxillofacial Pathology 23, no. 1 (январь – апрель 2019): 122–128, doi: 10.4103/jomfp.JOMFP_304_18.
60. Elijah O. Oyetola et al., “Salivary Bacterial Count and Its Implications on the Prevalence of Oral Conditions,” The Journal of Contemporary Dental Practice 20, no. 2 (1 февраля 2019): 184–189, https://pubmed.ncbi.nlm.nih.gov/31058633/.
61. Carol Perricone et al., “Porphyromonas gingivalis and Rheumatoid Arthritis,” Current Opinion in Rheumatology 31, no. 5 (сентябрь 2019): 517–524, doi: 10.1097/BOR.0000000000000638.
62. Eduardo GómezBañuelos et al., “Rheumatoid ArthritisAssociated Mechanisms of Porphy romonas gingivalis and Aggregatibacter actinomycetemcomitans,” Journal of Clinical Medicine 8, no. 9 (сентябрь 2019): 1309, doi: 10.3390/jcm8091309.
63. Zebunnissa Memon et al., “An Orthodontic Retainer Preventing Remission in Celiac Disease,” Clinical Pediatrics (Philadelphia) 52, no. 11 (ноябрь 2013): 1034–1037, doi: 10.1177/0009922813506254.
64. Kazumichi Abe et al., “Gut and Oral Microbiota in Autoimmune Liver Disease,” Fukushima Journal of Medical Science 65, no. 3 (9 января 2020): 71–75, doi: 10.5387/fms.2019-21.
65. Nikolaos G. Nikitakis, “The Autoimmunityoral Microbiome Connection,” Oral Diseases 23, no. 7 (октябрь 2017): 828–839, doi: 10.1111/odi.12589.
66. Ashutosh K. Mangalam, Meeta Yadav, and Rjwardhan Yadav, “The Emerging World of Microbiome in Autoimmune Disorders: Opportunities and Challenges,” Indian Journal of Rheumatol ogy 16, no. 1 (23 марта 2021): 57–72, doi: 10.4103/injr.injr_210_20.
67. Kilian, “The Oral Microbiome,” 657–666.
68. Shinichi Kuriyama, “The Relation between Green Tea Consumption and Cardiovascular Disease as Evidenced by Epidemiological Studies,” The Journal of Nutrition 138, no. 8 (1 августа 2008): 1548S–1553S, doi: 10.1093/jn/138.8.1548S.
69. Sabu M. Chacko et al., “Beneficial Effects of Green Tea: A Literature Review,” Chinese Medicine 5 (6 апреля 2010): 13, doi: 10.1186/17498546-5-13.
70. Xiaojie Yuan et al., “Green Tea Liquid Consumption Alters the Human Intestinal and Oral Microbiome,” Molecular Nutrition & Food Research 62, no. 12 (июнь 2018): 1800178, doi: 10.1002/mnfr.201800178.
71. David J. Weiss and Christopher R. Anderton, “Determination of Catechins in Matcha Green Tea by Micellar Electrokinetic Chromatography,” Journal of Chromatography A 1011, no. 1–2 (5 сентября 2003): 173–180, doi: 10.1016/s00219673(03)01133-6.
72. J. Steinmann et al., “Antiinfective Properties of Epigallocatechin-3-Gallate (EGCG), a Component of Green Tea,” British Journal of Pharmacology 168, no. 5 (март 2013): 1059–1073, doi: 10.1111/bph.12009.
73. Parth Lodhia et al., “Effect of Green Tea on Volatile Sulfur Compounds in Mouth Air,” Journal of Nutritional Science and Vitaminology (Tokyo) 54, no. 1 (февраль 2008): 89–94, doi: 10.3177 /jnsv.54.89.
74. Oghenekome Gbinigie et al., “Effect of Oil Pulling in Promoting Oro Dental Hygiene: A Systematic Review of Randomized Clinical Trials,” Complementary Therapies in Medicine 26 (июнь 2016): 47–54, doi: 10.1016/j.ctim.2016.02.011.
75. Buket Acar et al., “Effects of Oral Prophylaxis Including Tongue Cleaning on Halitosis and Gingival Inflammation in Gingivitis Patients: A Randomized Controlled Clinical Trial,” Clinical Oral Investigations 23, no. 4 (апрель 2019): 1829–1836, doi: 10.1007/s007840182617-5.
1. Ana M. Andrade, Geoffrey W. Greene, and Kathleen J. Melanson, “Eating Slowly Led to Decreases in Energy Intake within Meals in Healthy Women,” Journal of the Academy of Nutri tion and Dietetics 108, no. 7 (1 июля 2008): 1186–1191, doi: 10.1016/j.jada.2008.04.026.
2. Hongbin Guo et al., “Associations of Whole Grain and Refined Grain Consumption with Metabolic Syndrome: A MetaAnalysis of Observational Studies,” Frontiers in Nutrition 8 (1 июля 2021): 695620, doi: 10.3389/fnut.2021.695620.
3. Md. Ashraful Islam et al., “Trans Fatty Acids and Lipid Profile: A Serious Risk Factor to Cardiovascular Disease, Cancer and Diabetes,” Diabetes & Metabolic Syndrome 13, no. 2 (март-апрель 2019): 1643–1647, doi: 10.1016/j.dsx.2019.03.033.
4. María CorreaRodríguez et al., “Dietary Intake of Free Sugars is Associated with Disease Activity and Dyslipidemia in Systemic Lupus Erythematosus Patients,” Nutrients 12, no. 4 (15 апреля 2020): 1094, doi: 10.3390/nu12041094.
5. Sanjay Basu et al., “The Relationship of Sugar to PopulationLevel Diabetes Prevalence: An Econometric Analysis of Repeated CrossSectional Data,” PLoS One 8, no. 2 (27 февраля 2013): e57873, doi: 10.1371/journal.pone.0057873.
6. Laura O’Connor et al., “Intakes and Sources of Dietary Sugars and Their Association with Metabolic and Inflammatory Markers,”